Bisphosphonates in the treatment of osteoporosis. [electronic resource]
- Endocrinology and metabolism clinics of North America Sep 2012
- 487-506 p. digital
Publication Type: Journal Article; Review
1558-4410
10.1016/j.ecl.2012.04.007 doi
Anticarcinogenic Agents--administration & dosage Atrial Fibrillation--chemically induced Bisphosphonate-Associated Osteonecrosis of the Jaw--complications Bone Density Conservation Agents--administration & dosage Diphosphonates--administration & dosage Drug Monitoring Esophageal Neoplasms--chemically induced Female Femoral Fractures--chemically induced Gastrointestinal Diseases--chemically induced Humans Male Musculoskeletal Pain--chemically induced Osteoporosis--complications Osteoporosis, Postmenopausal--complications Risk Assessment Stroke--prevention & control